Bacterial Infections  >>  Humira (adalimumab)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Humira (adalimumab) / AbbVie
PIONEER (OLE), NCT01635764 / 2011-003478-98: Open-label Study of the Safety and Efficacy of Adalimumab in the Treatment of Hidradenitis Suppurativa

Completed
3
508
NA
adalimumab, Humira
AbbVie (prior sponsor, Abbott)
Hidradenitis Suppurativa
08/16
08/16

Download Options